OMERS Administration Corp’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.47M | Hold |
4,517
| – | – | 0.01% | 451 |
|
|
2025
Q1 | $1.22M | Sell |
4,517
-735
| -14% | -$198K | 0.01% | 518 |
|
|
2024
Q4 | $1.24M | Buy |
5,252
+891
| +20% | +$210K | 0.01% | 472 |
|
|
2024
Q3 | $1.2M | Hold |
4,361
| – | – | 0.01% | 485 |
|
|
2024
Q2 | $1.06M | Buy |
+4,361
| New | +$1.06M | 0.01% | 521 |
|
|
2023
Q4 | – | Sell |
-4,000
| Closed | -$708K | – | 294 |
|
|
2023
Q3 | $708K | Buy |
+4,000
| New | +$708K | 0.01% | 104 |
|